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Abstract: Osteosarcoma of the jaws is a relative rare malignant bone tumor. Like, its counterpart in the long bones, os-
teosarcoma affecting the head and neck region shows distinct yet diverse clinical, histologic and prognostic characteris-
tics. Its diagnosis is a challenge to histopathologists and is especially important in early stages to improve its prognosis. In 
the initial phase, it may present as nondescript swelling with an indolent growth rate, only to become overtly aggressive 
and malignant towards the later phase of the disease. This article reports on a case of an advanced osteosarcoma of the 
maxilla in a 42 year old woman who came for the evaluation of a swelling. The case was submitted for surgical interven-
tion and was followed by one recurrence till the time of reporting. This case illustrates that immunohistochemical staining 
of Vimentin, S-100 and CD 68 markers are useful to confirm the histologic diagnosis of osteosarcoma, along with radio-
graphic evaluation using CT scan and 3D imaging.  
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INTRODUCTION  
Although, the incidence of osteosarcoma (OS) among 
malignant tumors is low, it is still the most common primary 
tumor of bone [1]. It belongs to a family of lesions which 
have considerable diversity in histologic features and grades 
[2]. OS arising from the jaw comprises 2.1% of all malignant 
oral and maxillofacial tumours [3]. OS of jaw differs from 
OS of the long bones in its biological behavior, presenting a 
lower incidence of metastasis [4] and a better prognosis with 
approximately 40% 5-year survival rate as compared to 20% 
for non-jaw lesions [5].  
In the initial phase of the disease, OS may present as an 
unremarkable slowly progressing bony swelling, only to be-
come overtly aggressive and malignant towards the latter 
phase of the disease, thus imposing a challenge to accurate 
diagnosis [1]. Histologically, OS is classified into three sub-
types: osteoblastic, chondroblastic, fibroblastic [6]. How-
ever, it may have various degrees of differentiation and pro-
duce various kinds of extracellular matrix, thus producing a 
histologic pattern that may vary significantly, not only from 
one case to another, but also from area to area within the 
same case. OS are believed to arise from immature bone-
forming cells or through neoplastic differentiation of other 
immature mesenchymal cells into osteoblasts. Three main 
factors generally are purposed to be etiologically significant 
in their development -irradiation, preexisting benign bone 
disorders and trauma [4]. OS tumorigenesis has been linked 
to alterations in several genes. The first association of OS  
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with an inherited predisposition was observed in patients 
with bilateral retinoblastoma. This association was con-
firmed by identification of the retinoblastoma susceptibility 
gene (RB1) on human chromosome 13 which showed high 
percentage of mutations in OS [7]. The second gene associ-
ated with OS was the p53 gene where the mutations in the 
p53 gene were first observed in sporadic OS [8, 9]. 
Here, we present a rare case report of OS in a 42 year old 
female patient, who had a swelling in the maxillary region 
with varied histologic appearance mimicking proliferative 
reactive lesions, thus posing a challenge to pathologic diag-
nosis and effective surgical management of the case. 
CASE REPORT 
A 42 year old female patient presented with a solitary 
swelling in the left middle-third of the face. The swelling 
had been present for a month. Extraorally, the swelling 
measured around 2x2cms (Fig. 1A). It was firm in consis-
tency, tender on palpation and the overlying skin appeared 
stretched and shiny. There was associated lymphadenopathy. 
Intraorally, the swelling extended anterioposteriorly from 
distal aspect of 23 to distal aspect of 27 (Fig. 1B). Lateral 
extension revealed the obliteration of the buccal vestibule, 
medially up to the midpalatal area. A root stump was present 
in relation to upper left first premolar. Investigations like 
intra oral periapical radiograph showed periapical rarifying 
osteitis with increase in the width of periodontal ligament 
membrane in relation to 26 (Fig. 1C). Orthopantamograph 
revealed a root stump in relation to 24 and increase width of 
periodontal ligament membrane with loss of lamina dura in 
relation to 26 (Fig. 1D). Considering the findings, a provi-
sional diagnosis of infected periapical pathology in relation 
to 26 was given. Patient was advised extraction of the root 212    The Open Dentistry Journal, 2010, Volume 4  Desai et al. 
stump and endodontic therapy for 26. Following treatment, 
patient reported back to the hospital within two weeks with 
significant increase in the size of the swelling from 2x2 cms 
at the first visit to 6x5 cms (Fig. 2A). On examination, a foul 
smelling, reddish black mass measuring 6x5x6 cms, pedun-
culated swelling was seen arising from the extracted socket 
of 24 (Fig. 2B). Palpatory findings revealed the swelling to 
be firm in consistency, tender on palpation and slight bleed-
ing on probing. These features suggested a provisional diag-
nosis of central giant cell granuloma. Additional investiga-
tions were done that included hematological investigation 
which revealed increase in blood glucose and ESR levels. 
Radiographic investigations of paranasal sinus showed hazi-
ness of the left maxillary sinus, with erosion of infra orbital, 
medial and lateral walls. Computed tomography revealed a 
large expansile lesion arising from the lateral wall of the 
superior alveolus of the maxilla of the left side, extending 
into the left maxillary sinus and eroding all the walls of the 
maxillary sinus (Fig. 2D). CT morphology suggested the 
possibility of a giant cell tumor. 
An incisional biopsy was performed and histopathologi-
cal findings showed a nonspecific infection suggesting an 
inaccurate biopsy site (Fig. 2C). A repeat biopsy was re-
quested in relation to deeper areas. However, patient re-
ported back within two days of incisional biopsy with a fur-
ther increase in the size of the swelling with the lesion pro-
truding out of the oral cavity causing inability to close the 
mouth (Fig. 3A). An immediate partial maxillectomy was 
done based on the clinical features, computed tomography 
findings, to avoid further encroachment of the base of the 
skull (Fig. 3B). The resected mass weighed about 250gms, 
measuring 14x8 cms (Fig. 3C). Histopathology showed the 
lesion to be composed of proliferating fibroblasts along with 
bundles of collagen fibers. A markedly cellular lesion com-
prising of mature proliferating fibroblasts with infrequent 
mitosis and occasional atypia was seen (Fig. 4A). There was 
a presence of abundant inflammatory cells along with few 
reactionary giant cells, interspersed with a myxoid back-
ground (Fig. 4B). Storiform pattern of arrangement of fibro-
blasts was also seen, with the fibroblasts showing atypia in 
relation to size and shape. Invasion into the adjacent adipose 
tissue was also noted. Immunohistochemical staining was 
performed with vimentin markers and S-100 protein. 
Vimentin positivity proved the myofibroblastic nature of the 
spindle cell lesion (Fig. 4C). S-100 was negative, thus ruling 
out neural tumours (Fig. 4D). Based on the clinical picture, 
rate of growth of the lesion and histopathological findings, a 
final diagnosis of fibrosarcoma was given. Patient reported 
back with an uneventful healing following which functional 
and esthetic reconstruction was done by giving an obturator. 
After hemimaxillectomy, chemotherapy was administered 
which included Cysplatin 80 mg/m2 on day 1 along with 5 
 
Fig. (1). A. Extra oral swelling measuring 2x2 cms in the left middle third of the face. B. Swelling extending anterioposteriorly from the 
distal aspect of 23 to distal aspect of 27. C. Intraoral periapical radiograph showing periapical rarifying osteitis with increase in width of 
periodontal ligament membrane in relation to 26. D. Orthopentamograph showing root stump in relation to 24 and increase width of perio-
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Fluorouracil - 500mg/m2 which was administered on day 1 
to 4. This resulted in partial response of the tumour with 
stoppage of bleeding. Patient also underwent a course of 
radiotherapy (60 Gy over 6 weeks). The decision to give 
radiotherapy was made taking into consideration the large 
size of the lesion along with a history of recurrence. After 
surgery, an acrylic plate obturator was placed which was to 
be replaced by a cast partial hollow bulb closed obturator.  
There was no evidence of recurrence for six months after 
which patient reported back with a complaint of pain in the 
same region with difficulty in eating and carrying out routine 
oral hygiene procedures. Extra orally a diffuse solitary swel-
 
Fig. (2). A. Swelling measuring 6x5 cms. B. Reddish black pedunculated mass measuring 6x5x6 cms from the extracted tooth socket 24. C. 
Histopathology of incisional biopsy showed a non specific infection. D. Computed tomography showing the extension of the swelling into 
the left maxillary sinus & causing erosion of all the walls.  
 
Fig. (3). A. Further increase in the size of the swelling causing inability in closing the mouth. B. Immediate partial maxillectomy being 
carried out. C. Complete resected mass measured 14x8 cms. 214    The Open Dentistry Journal, 2010, Volume 4  Desai et al. 
ling measuring 2x2 cms was seen in the left middle-third of 
the face with associated lymphadenopathy. Intra orally, the 
swelling was measuring 2x3 cms in the region of earlier 
maxillectomy (Fig. 5A). CT scan was performed for the 
same, and it revealed a soft tissue density present heteroge-
neously in the region of left pterygopalatine fossa, extending 
superiorly and medially into the maxillary sinus and there 
was loss of fat plane with lateral pterygoid muscle. With 3D 
imaging, erosion of floor of the left orbit, left medial and 
lateral pterygoid plates were evident, suggesting a residual 
lesion (Fig. 5B). 
Elaborate hematological investigations with electrolyte 
levels were done which revealed an increase in lymphocyte, 
ESR rate and hemoglobin level. The duration of the lesion 
with clinical behavior suggested possibilities of giant cell 
reparative granuloma, chronic fungal or bacterial infections, 
fibrosarcoma and osteosarcoma. 
Treatment rendered was immediate resection to prevent 
the encroachment of the mass. The resected soft tissue mass 
was irregular in shape, grayish white in colour, measuring 
4x3 cms with white solid areas seen on the cut surface. 
Histopathology revealed storiform pattern of arrangement of 
fibroblasts interspersed with atypical spindle cell to round to 
oval cells (Fig. 5C). Faint eosinophillic areas representing 
tumour osteoid was seen within the tumour mass. Osteo-
clasts like giant cells were seen in close association to tu-
mour osteoid (Fig. 5D). Few areas suggested histiocytic type 
cells admixed with atypical fibroblasts and mitotic figures 
were also seen (Fig. 5E). The entire lesion varied in his-
tological appearance from area to area. An immunohisto-
chemical study was also carried out with CD68 to know the 
nature of histiocytes, but its focal positivity ruled out the 
malignant fibrous histiocytoma variant (Fig. 5F). Proliferat-
ing fibroblasts along with the typical tumour osteoid was 
more favoring a sarcomatous lesion like OS. A final diagno-
sis of fibroblastic variant of OS was given. Alveolar bone 
graft with osseointegrated implants has been considered on 
this patient at a later date.  
DISCUSSION  
OS are primarily bone producing malignant tumours aris-
ing most frequently in the long bones. Jaw OS usually occur 
one to two decades later than that of OS of other regions. 
Patients with OS usually have nonspecific clinical symp-
toms, the most common of which is pain associated with the 
swelling presenting from weeks or months. It has a bimodal 
age distribution, with a major peak in the second decade and 
a somewhat smaller peak after the age of 50. However, bi-
modal distribution of jaw lesions differ from those in the 
apppendicular skeleton, with the first peak occurring some-
what later, in the third decade [10]. The present case, with a 
critical clinical appearance of pain and swelling, is in accor-
dance with the literature related to jaw OS, where patient 
presents with clinical symptoms in 3
rd and 4
th decade of life. 
These neoplasms often show typical behavior in the initial 
 
Fig. (4). A. Histopathology showed a markedly cellular lesion with proliferating fibroblasts. B. Presence of few reactionary giant cells. C. 
IHC showing positivity to Vimentin marker. D. Immunohistochemistry with S-100 marker being negative. Fibroblastic Variant of Jaw Osteosarcoma  The Open Dentistry Journal, 2010, Volume 4    215 
phase presenting as a nondescript swelling, only to become 
overly aggressive in the later phase of the disease [11]. This 
was seen in our case as well, where the initial swelling was 
an unremarkable swelling leading to a preliminary diagnosis 
of periapical pathology. However, the swelling became sig-
nificantly aggressive within a short span of time which led to 
emergency management of the lesion. 
Histologically, although OS of jaws are almost similar to 
that of long bones, they are always better differentiated than 
the latter [12]. It has been reported that production of osteoid 
by malignant cells, even in small amounts, is diagnostic of 
OS [13, 14]. Depending on the relative amounts of osteoid, 
cartilage, or collagen fibres present in the extracellular 
matrix, OS are categorized histopathologically into 
 
Fig. (5). A. Recurrent lesion measuring 2x3 cms in the maxillectomy region. B. 3D-imaging showing erosion of the floor of the left orbit. C. 
Storiform pattern of arrangement of fibroblasts with atypical; spindle cells. D. Osteoclasts like giant cells closely associated with tumour 
osteoid. E. Histiocytic type of cells admixed with atypical fibroblasts and atypical mitotic figures. F. Immunohistochemical CD68 marker 
study showing focal positivity for histiocytes. 216    The Open Dentistry Journal, 2010, Volume 4  Desai et al. 
osteoblastic, chondroblastic, or fibroblastic subtypes [6]. In 
reality, most OS exhibit varying amounts of these three cell 
types and matrix [1]. Therefore, division into any one of 
these types is arbitrary and is generally meant to signify 
greater than 50% prevalence of any of these histologic types 
[1]. OS are known to vary in histologic pattern within same 
case with areas showing storiform pattern of fibrosarcoma to 
atypical elongated histiocytic like cells representing histio-
cytic tumours. Storiform pattern of fibroblasts with prolifer-
ating fibroblasts along with bundles of collagen fibers led to 
the diagnosis of fibrosarcoma in the initial biopsy in the pre-
sent case. Further, there was a predominance of spindle cell 
proliferation in sweeping fascicles along with infrequent 
mitosis, occasional atypia and with focal areas showing giant 
cells, which again favored a diagnosis of fibrosarcoma.  
Immunohistochemistry forms an integral part of patho-
logic diagnosis that aids in arriving at an accurate histopa-
thological diagnosis. Vimentin, S-100 and CD68 markers 
were used to help in reaching the diagnosis. Vimentin was 
constantly positive with S-100 showing negativity, thus rul-
ing out the possibility of neural tumours. Focal positivity 
with CD68 added on to the fibrohistiocytic nature of the tu-
mours as quoted in the literature, to be one of the variants of 
OS [15]. Such challenging cases often pose a problem in 
executing a definitive surgical treatment option.  
Radiographic evaluation is important in diagnosing OS as 
clinical symptoms like pain, swelling, paresthesia, and 
loosening of teeth are not specific [16]. Better knowledge of 
the radiological features can lead to an earlier diagnosis thus 
improving its prognosis [17]. Characteristic radiographic 
features include destruction of the cortical plates, widening 
of periodontal ligament space and perpendicular spiculated 
pattern of new periosteal bone formation [18]. However, 
these characteristic features are often missing and thus, OS is 
difficult to interpret as a result of varied appearance ranging 
from purely osteolytic or osteoblastic lesion, to a mixture of 
both [10]. The recurrent nature of the lesion with its aggres-
sive nature, in our case, was confirmed by CT scan, where 
extensions into the orbit promoted a thorough sampling of 
the lesion. The classic appearance of tumour osteoid was the 
characteristic finding that led to the diagnosis of OS. Radio-
graphs suggested a lytic destructive lesion while CT findings 
ruled out any metastasis. 
The recurrence rate in large, bulky tumours is 80% 
within 24 months. Early diagnosis and radical surgery are the 
key factors for the better survival rate in this condition. 
Treatment of this lesion is radical surgery consisting of com-
plete resection along with a margin of normal surrounding 
tissue, usually accompanied by chemotherapy. The best sur-
vival rate of five years was noted with radical surgery [12]. 
Anatomic limitations in face can cause some difficulties in 
achievement of uninvolved margins [19]. The combination 
of closed margins and poor histologic response appears to be 
the reason for high local recurrence of these lesions. The 
prognosis for patients after local recurrence of OS is poor. 
Recent studies have focused on new markers for early de-
tection of OS. Park et al. in their recent study showed by 
immunohistochemistry that high-grade OS of the jaws had a 
higher expression rate of proteins involved in regulation of 
growth and metastasis of cancer cells (ezrin and Metastatic 
tumour antigen) suggesting that their positivity can be used 
as additional prognostic markers in OS of the jaw [20]. 
Another study analyzed the clinicopathological features and 
immunohistochemical expression of p53, MDM2, CDK4, 
PCNA and Ki67 proteins in 25 head and neck OS and found 
52% positivity for p53, 24% for MDM2, 84% for CDK4, 
92% for PCNA and 88% for Ki-67 suggesting PCNA as one 
of most favourable prognostic marker [21] . Another study 
suggested the role of 12q13-15 genes in OS of the jaws with 
amplification and overexpression of these genes might help 
in detecting high-grade tumours [22]. 
Response to chemotherapy (CT) is best seen in fibroblas-
tic subtypes and poorest in chondroblastic subtype [11]. 
Multimodality therapy using chemotherapy and radiation 
treatment (RT) has shown improvement in survival rates in 
the OS of the extremity, from 20% to 70%, which is better 
than the 40% survival rate reported for jaw OS [23]. A recent 
study which was performed to evaluate the outcomes of 
multimodality treatment in patients with OS of the 
jaw/craniofacial region with positive/uncertain resection 
margins, found that combined modality treatment, 
comprising of surgery and RT (median dose, 60 Gray) 
significantly improved local control (P = 0.006) and overall 
survival (P < .0001) as compared to surgery alone [24]. In 
the case presented here, patient was subjected to partial max-
illectomy coupled with RT & CT and one episode of recur-
rence of tumour was reported at the time of write up, at a 
follow up for past one year. Multidimensional approaches 
including conventional surgical and prosthetic procedures, 
however, should be considered in accordance with the indi-
vidual patient and specific defect. 
Various new treatment modalities are being investigated 
for the treatment of OS of the jaws. A recent study focused 
on the expression of inducible nitric oxide synthase (iNOS) 
in OS of the jaw, and its relationship with tumour 
angiogenesis and clinicopathological characteristics. They 
concluded that iNOS may promote tumour angiogenesis in 
OS of the jaw and may present an important target in anti-
tumour therapy [2]. Development of microvascular tissue 
transfer now offers various reconstructive options and has 
greatly improved the result of mid-face reconstruction [25]. 
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